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Abstract
Standard proteomics methods allow the relative quantitation of levels of thousands of proteins in two or more samples.
While such methods are invaluable for defining the variations in protein concentrations which follow the perturbation of a
biological system, they do not offer information on the mechanisms underlying such changes. Expanding on previous work
[1], we developed a pulse-chase (pc) variant of SILAC (stable isotope labeling by amino acids in cell culture). pcSILAC can
quantitate in one experiment and for two conditions the relative levels of proteins newly synthesized in a given time as well
as the relative levels of remaining preexisting proteins. We validated the method studying the drug-mediated inhibition of
the Hsp90 molecular chaperone, which is known to lead to increased synthesis of stress response proteins as well as the
increased decay of Hsp90 ‘‘clients’’. We showed that pcSILAC can give information on changes in global cellular proteostasis
induced by treatment with the inhibitor, which are normally not captured by standard relative quantitation techniques.
Furthermore, we have developed a mathematical model and computational framework that uses pcSILAC data to
determine degradation constants kd and synthesis rates Vs for proteins in both control and drug-treated cells. The results
show that Hsp90 inhibition induced a generalized slowdown of protein synthesis and an increase in protein decay.
Treatment with the inhibitor also resulted in widespread protein-specific changes in relative synthesis rates, together with
variations in protein decay rates. The latter were more restricted to individual proteins or protein families than the variations
in synthesis. Our results establish pcSILAC as a viable workflow for the mechanistic dissection of changes in the proteome
which follow perturbations. Data are available via ProteomeXchange with identifier PXD000538.
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Introduction
Monitoring protein abundances and their evolution throughout
biological processes is critical for understanding the mechanisms
by which cellular functions are achieved. The required protein
abundances in the cell are maintained through a series of
concerted and very tightly regulated processes, including DNA
transcription [2], RNA processing and degradation [3] and
translation [4] [5], through to the modification [6], localization
and degradation (reviewed in [7]) of the protein products.
Ultimately, a dynamic balance of protein abundances is accom-
plished as a result of the coordinated control of all these processes.
Strategies for measuring how these processes contribute to
attaining an overall dynamic balance of protein abundances have
evolved from the quantitation of mRNAs to the direct estimation
of protein levels on a high-throughput scale using quantitative
proteomics. Until about a decade ago, it was assumed that mRNA
levels largely determine protein levels. It is now accepted that post-
transcriptional and translational control can lead to a poor
correlation between mRNA and protein abundances (reviewed in
[8,9]).
The development of proteomics techniques during the last
decade has given investigators the capacity to systematically
quantitate net changes, or relative abundances of thousands of
proteins (reviewed in [10]). Notably, the introduction of metabolic
stable-isotope labeling techniques for quantitation, especially
SILAC [11,12], has offered us a powerful and accurate tool for
the analysis of changes in the proteome. In its standard version
(stSILAC), SILAC compares in a mixture a completely ‘‘heavy’’
labeled proteome from a cell culture (first condition), with an
unlabeled ‘‘light’’ proteome derived from another cell culture
(second condition).
Although standard quantitative proteomics techniques are
essential to identify and measure variations in protein abundances,
they are not adapted to determine if such variations are due to
changes in synthesis rates, decay rates, or a combination of both.
Nor are these techniques able to quantitate other properties such
as turnover, which may give an indication of the intrinsic stability
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and half-life of proteins. Now, the understanding of the
mechanism(s) underlying variations in protein levels can provide
information that can be important to interpret the changes
observed and formulate hypotheses on the pathways involved.
Kinetic parameters of proteins, such as rates of synthesis and
degradation, turnover, and half-life, have been classically studied
by metabolic pulse- and/or chase labeling experiments using 35S-
methionine (i.e. [13–16]). Radioactive labeling offers remarkable
sensitivity, but imposes to focus on one or a few proteins of interest
to obtain accurate quantitation, and is thus hardly suitable for
high-throughput studies.
In recent years, metabolic labeling with stable isotopes has been
increasingly used for measuring protein turnover, most often by
culturing cells for a limited time in media containing stable
isotope-labeled amino acids, resulting in partial (‘‘pulse’’) labeling.
After extraction, digestion, and identification of proteins by
tandem MS, the heavy/light ratios determined for peptides
provide the level of label incorporation during the time frame
considered. In steady-state systems, where the concentration of all
proteins is assumed to be constant, incorporation ratios allow to
measure protein turnover and half-life. Protein turnover analysis
has been pioneered by the group of R. Beynon, who established
theoretical principles and carried out both in vitro and in vivo studies
[17–19]. SILAC-like pulsed labeling was later used for targeted
analyses to measure the flux of ribosomal proteins in nucleoli
[20,21] and to determine turnover for several hundred of blood
and tissue proteins in the mouse [22], yielding an overview of in
vivo protein turnover. Total cell labeling with 15N has also been
used for turnover measurements in both mammalian and
microbial systems [23–27]. Although most turnover studies relied
on isotope labeling and mass spectrometry, GFP-tagging and other
classical biochemical approaches have also been used to determine
turnover [28–30]. SILAC based strategies are nevertheless
preferred for the large scale analysis of protein levels and protein
turnover [31] [32]. In turn, although protein turnover can be an
informative parameter measurable in a steady-state system, a more
comprehensive analysis of the dynamics of protein levels should
aim at determining the mechanistic components involved, i.e.
protein synthesis and decay rates, in the steady state and/or in a
perturbed system. The ‘‘pulsed SILAC’’ (pSILAC) method was a
first step in this direction, developed to compare levels of newly
synthesized proteins in two conditions by implementing a 3-
channel labeling strategy, where labeling was performed with three
isotopomers of arginine [1,33]. Interestingly, the technique was
applied to study the influence of microRNAs (miRNAs) on global
levels of translation [34]. With a different focus and using an
innovative SILAC labeling scheme, rates of protein synthesis,
decay, and turnover, were determined in HeLa cell extracts, as
well as in separate cytoplasmic, nuclear, and nucleolar compart-
ments [35,36]. Moreover, Japayal et al [37] combined SILAC with
iTRAQ (Isobaric Tags for Relative and Absolute Quantitation)
labeling to measure turnover and degradation rates in Streptomyces
coelicolor.
In spite of the significant progress made so far, most of the work
focusing on protein kinetic parameters was aimed at analyzing a
single, steady-state system. The goal of the present work was to
develop a technique which could yield, within the same
experiment, information on protein synthesis and decay rates in
two conditions, a steady-state and a perturbed cellular system. To
test and validate our method we needed a model cellular system
which, upon perturbation, undergoes numerous known changes in
both protein synthesis and degradation. We chose to study the
inhibition of the Hsp90 molecular chaperone by the ansamycin
antibiotic geldanamycin (GA). Hsp90, a highly conserved chap-
erone, is believed to be one of the master regulators of proteostasis
in eukaryotic cells under physiological or stress conditions
(reviewed in [38]). Hsp90 interacts with a large array of cellular
proteins, which depend on it to reach their active conformation. A
critical stabilizing interaction is assumed between Hsp90 and its
‘‘clients’’, defined as a set of proteins strongly dependent on
Hsp90, of which many take part in signaling pathways. Treatment
of cells with specific inhibitors of Hsp90, such as GA, induces the
depletion of many or most Hsp90 ‘‘clients’’, mediated mostly by an
increased degradation [39]. At the same time, Hsp90 inhibition
induces a generalized protein folding cellular stress that triggers an
increase in synthesis of molecular chaperones [32,40–42], in a
mode similar to the heat shock response [43].
Here, we describe a novel technique called ‘‘pulse-chase
SILAC’’ (pcSILAC), which yields comparative data on both
protein decay and novel protein synthesis in two conditions. When
tested on Hsp90 inhibition of a cellular system, increased decay of
Hsp90 clients and increased synthesis of stress response proteins
were detected within the same pcSILAC experiment. Using this
technique, we performed global, as well as individual protein
assessment of the dynamics of protein decay and synthesis in both
control and inhibitor-treated cells. Moreover, we developed a
mathematical framework, tailored to pcSILAC, to calculate
protein degradation constants (and hence half-lives) and synthesis
rates for both cellular states.
Experimental Procedures
Materials
All isotope labeled amino acids were from Cambridge Isotope
Laboratories (CIL), Andover, MA, USA. The specially formulated
media for SILAC were from Cell Culture Technologies, Grave-
sano, Switzerland, while dialyzed fetal bovine serum (FBS) and
antibiotics were from Invitrogen (Carlsbad, CA, USA). Sequenc-
ing grade modified Trypsin was from Promega. All other
chemicals were from Sigma-Aldrich.
Methods
Experimental design. Two independent pcSILAC experi-
ments were performed, both of which included duplicates with
inversion of labels and extraction of total mRNA at two time
points (t = 5h, 19h) and protein at three time points (t = 6, 12, 20h).
The two experiments, described in Figure S1, differed in that in
experiment 1 GA was added immediately after medium exchange
(t = 0), while in experiment 2 the inhibitor was added 2h later. For
this reason, their results are presented separately. The main text
mainly presents data from experiment 2 (full data are reported in
Tables S1, S3 and S4), while similar plots for experiment 1 are
given in the supplementary figures and the data in Tables S1, S2
and S4.
Pulse-chase SILAC and standard SILAC experiments.
Jurkat T-lymphocytes clone J77.20 were a kind gift of Dr. Oreste
Acuto, University of Oxford and have been previously described
[44,45]. Cells were cultured in Roswell Park Memorial Institute
(RPMI) 1640 medium with 10% (v/v) dialyzed FBS for all
experiments. In the pcSILAC labeling scheme (Fig.1 and Fig. S1),
pre-exchange medium (PEM) was used to culture and fully label
the cells. After medium exchange labeling proceeded by culturing
cells in post-exchange medium (POM). Stable Isotope labeled
amino acids were included in the ‘heavy-pcSILAC PEM’
(containing 13C6
15N4-L-arginine) and in the ‘medium-pcSILAC
PEM’ (13C6-L-arginine) at 100 mg/l, whereas proline was supplied
at 180 mg/l, that is a 9-fold excess over its standard concentration
in RPMI medium. Labeling under pre-exchange conditions was
Pulse-Chase SILAC for Protein Synthesis and Decay
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achieved by culturing the cells for a minimum of 2 weeks to allow
for at least 5 cell divisions. Before start of the experiments, tests
were carried out to verify that heavy labeling was .98% and Arg
to Pro conversion was lower than 5%. Cells were centrifuged and
rinsed with PBS (phosphate buffered saline) before transfer from
heavy-pcSILAC PEM to heavy-pcSILAC POM (same as heavy-
pcSILAC PEM, but containing13C6
15N2-L-lysine and light argi-
nine), or from medium-pcSILAC PEM to medium-pcSILAC
POM (same as medium-pcSILAC PEM, but containing 2H4-L-
lysine and light arginine). After the exchange of media, heavy-
pcSILAC labeled cells were treated with 1 mM geldanamycin,
while medium labeled cells were treated with the same volume of
DMSO. Further culturing of the cells in POM (after drug
treatment) was conducted for 20h, and aliquots of cells were taken
at 6 and 12h after drug treatment. The experiment consisted of
two independent biological replicates and an additional stSILAC
control, respectively. In the second replicate, the treatment was
inverted, i.e. GA was added to medium labeled cells (Fig. S1 for
experimental design). For determination of growth, cells were
counted using a Neubauer cell in triplicate at t = 0 and t = 20h for
each biological replicate (cell numbers are reported in Table S1).
Viability was assessed by trypan blue exclusion.
Cell lysis, protein extraction, digestion and fraction-
ation. Cells harvested from any of the previously described media
Figure 1. Labeling, measurable parameters and data obtained from pcSILAC experiments. A) Protein labeling scheme for pcSILAC
experiments. Two cell cultures were fully labelled only on Arg residues before cell treatments. For example, cells to be treated later with HSP90
inhibitor were fully labelled with 13C6
15N4-L-arginine (R10/K0) (‘‘heavy’’ cells) while cells to be used as control were fully labelled with
13C6-L-arginine
(R6/KO) (‘‘medium’’ cells). At the start of the experiment, ‘‘heavy’’ cells were transferred into a medium containing light R (R0) and ‘‘heavy’’ K
(13C6
15N2-L-Lys, referred to as R0/K8 medium), while ‘‘medium’’ cells were transferred to a medium containing light R (R0) and ‘‘medium’’ K (
2H4-L-
lysine, referred to as R0/K4 medium). GA or DMSO as a control were added either simultaneously or later, depending on the experiment. Cells were
harvested and lysed at various time points to produce extracts that were mixed before analysis. B) Conceptual view of the levels of a hypothetical
protein in a mixture of two (control and treated) pcSILAC-labeled samples. Pre-existing protein is fully labeled R6/K0 and R10/K0 (light and dark
brown), respectively for the control and treated sample. Newly synthesized protein is labeled R0/K4 (control, pink) and R0/K8 (treated, blue). The
SILAC (H/M) ratios for R- and K-containing peptides therefore measure the ratios of preexisting and newly synthesized proteins at time t. C) examples
of pcSILAC spectra for peptides from the tyrosine kinase LCK (left, peptide IPYPGMTNPEVIQNLER at t = 6h, z = 2) and the chaperone DNAJB1
( =Hsp40) (right, peptide EGDQTSNNIPADIVFVLK at t = 20h, z = 2).
doi:10.1371/journal.pone.0080423.g001
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were rinsed 3 times with PBS before lysis. Cells were lysed in 4%
SDS, 100 mM Tris/HCl pH 7.5, 100 mM DTT followed by
heating at 95uC. After centrifugation, protein concentrations were
measured by gel electrophoresis, coomassie blue staining and
densitometry with comparison against a pre-quantitated standard
cell extract. Equimolar extracts from light/heavy or heavy/
medium labeled cells were combined, alkylated with iodoaceta-
mide and digested using the filter assisted sample preparation
(FASP) method as described [46]. The obtained peptide mixtures
(200 mg total material) were desalted on SepPak C18 cartridges
(Waters Corp., Milford, MA), dried, dissolved in 4M Urea with
0.1% Ampholytes pH 3–10 (GE Healthcare) and fractionated by
off-gel focusing as described [47]. The 24 fractions obtained were
desalted on a micro tSepPak C18 96-well plate (Waters Corp.,
Milford, MA), dried and resuspended in 0.1% formic acid, 3% (v/
v) acetonitrile for LC-MS/MS analysis.
Mass spectrometry analysis. Digests were analyzed on a
hybrid linear trap LTQ-Orbitrap Velos mass spectrometer
(Thermo Fisher, Bremen, Germany) interfaced via a nanospray
source to a Dionex RSLC 3000 nanoHPLC system (Dionex,
Sunnyvale, CA, USA). Peptides were separated on a reversed-
phase Acclaim PepMap nano-column (75 mm ID615 cm, 2.0 mm,
100 A, Dionex) with a gradient from 5 to 85% acetonitrile in 0.1%
formic acid (total time: 120 min). Full MS survey scans were
performed at 60’000 resolution. In data-dependent acquisition
controlled by Xcalibur 2.1 software (Thermo Fisher), the twenty
most intense multiply charged precursor ions detected in the full
MS survey scan were selected for CID fragmentation in the LTQ
linear trap and then dynamically excluded from further selection
during 120s. The window for precursor isolation was of 3.0 m/z
units around the precursor. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the PRIDE
partner repository [48] with the dataset identifier PXD000538.
MS data analysis: identification and quantitation. MS
Data were analyzed and quantitated using MaxQuant version
1.0.13.13 [49], combined with Mascot (Matrix Science, London,
UK) version 2.3. Peak lists were generated with MaxQuant with
standard parameters. Database searches were performed on the
IPI (International Protein Index) Human database (version 3.68),
filtered to keep only the entries mapping a Swiss-Prot identifier
(34743 entries actually searched) in order to maximize sequence
and annotation quality in further analysis steps. Cleavage
specificity was trypsin (cleavage after K, R, no cleavage at KP,
RP) with two missed cleavages. Mass tolerances were of 7 ppm for
the precursor and 0.5 Da for CID tandem mass spectra. The
iodoacetamide derivative of cysteine was specified as a fixed
modification, and oxidation of methionine and protein N-terminal
acetylation were specified as a variable modifications. Protein
identifications were filtered at 1% false discovery rate (FDR)
established by MaxQuant against a database of reversed
sequences. A minimum of one unique peptide was necessary to
discriminate sequences which shared peptides. Sets of protein
sequences which could not be discriminated based on identified
peptides were listed together as protein groups and are fully
reported in the tables S1, S2 and S3. Details of peak quantitation
and protein ratio computation by MaxQuant are described
elsewhere [50]. All proteins with quantitated values (minimum
evidence count = 1) were initially retained to be subjected to
filtering in subsequent steps (see below).
pcSILAC-specific data analysis. All the subsequent filter-
ing steps were carried out automatically with a pipeline of custom-
made Perl scripts (Perl v5.10.1, scripts available in File S1). Protein
group tables from MaxQuant were further processed to remove
contaminants annotated in the database and matches to reverse
sequences. Further 63 proteins from an internal laboratory list of
65 environmental contaminants were also removed. Next, the
proteinGroup.txt table and the evidence.txt table were then used
as input for the discriminate_KR_peptides.pl (file S1) script. The script
extracted all quantitation values (normalized and non-normalized)
from the evidence file, separated quantitation values of K- and R-
containing peptides and calculated log2 of medians for K and R
‘‘channels’’ for each protein group in each experiment. Mixed-
label peptides (containing both K and R) were discarded. When
needed, normalization for each experiment was checked and
adjusted by translation based on the median. Further on, data
values with less than 3 evidence counts were removed from the
tables.
Removal of subsets, update of protein annotation and
alignment of datasets. To simplify post-analysis comparisons
of pcSILAC and standard SILAC datasets, subset proteins
(identified with a subset of peptides) were removed from the
protein groups. To ensure that the UniProt, GO (Gene Ontology),
KEGG (Kyoto Encyclopedia of Genes and Genomes) and PFAM
(Protein FAMilies) annotations were completely up-to-date, a Perl
script (File S1) automated REST (REpresentational State Trans-
fer) requests to the UniProt (http://www.uniprot.org/uniprot/)
and EBI websites (http://www.ebi.ac.uk/QuickGO/
GAnnotation) and SOAP (Simple Object Access Protocol) requests
to the KEGG website (http://soap.genome.jp/KEGG.wsdl), as
well as re-import of these data into the result table on the basis of
the simplified protein groups. All sequences identified with the
same number of peptides were retained in the protein groups.
When necessary, protein groups in analyzed datasets from
pcSILAC and standard SILAC were matched by IPI identifiers.
Only when all IPI identifiers in a protein group were identical in
two datasets, the protein groups and quantitative values were
matched and aligned in a joint table.
Modeling and computational steps. Construction of the
mathematical model and computational steps are described in the
results section and in detail in supplementary information S1.
Other data analysis steps. Enrichment analysis of kinetic
parameters was performed with the 1D annotation enrichment
algorithm of the software package Perseus as described [40] on
Gene Ontology (GO), KEGG and PFAM terms. The Benjamini-
Hochberg correction with threshold at 0.02 was applied to filter
GO enrichment results. Plots and further analysis were performed
with the R software package.
Results
Cellular system and experimental setup
Jurkat cells (derived from a T-cell leukemia) were grown in
RPMI medium modified for SILAC labeling and then treated with
1 mM GA. Under these conditions, drug treatment reduced cell
proliferation (table S1) and induced a cell cycle arrest but did not
cause detectable levels of apoptosis within the time frame of the
experiment (Fierro-Monti et al., accompanying manuscript).
Description and conceptual view of the pulse-chase
SILAC strategy
In classical pulse-chase experiments, cells are grown for a short
time in a medium containing 35S-methionine to radioactively label
proteins produced in the selected time frame (pulse). After this, the
cells are transferred into a medium containing an excess of
unlabeled amino acid and analyzed after variable times (chase).
The labeling allows tracing the subsequent evolution of the
abundance of a temporally defined pool of radioactive protein(s)
Pulse-Chase SILAC for Protein Synthesis and Decay
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without interference by the polypeptides synthesized later. A
general concept in pulse and chase experiments is thus the
possibility to differentiate, through the incorporation of labeled
amino acids, pre-existing proteins from proteins synthesized
after medium exchange. The application of this concept using
stable isotope labeled amino acids and MS detection has
resulted in the pulsed SILAC (pSILAC) strategy, which can
measure the amount of newly synthesized protein accumulating
after a medium exchange or, more precisely, the ratio new/old
protein at a given time. Such a label replacement ratio can be
used, if the system can be assumed to be at steady-state i.e. has
constant protein concentrations, to calculate protein half-lives.
pcSILAC takes the concept one step further, by measuring at
the same time the levels of new proteins and the evolution of the
levels of pre-existing proteins. Furthermore, through SILAC
multiplexing and amino acid encoding as it is done in pcSILAC,
levels of new/old proteins in two cellular conditions can be
compared in the same experiment. The main difference with the
classical radioactive pulse-chase is that in pcSILAC the pulse
and chase measurements are performed on distinct pools of
proteins, while in the classical scheme they concern one and the
same population.
The labeling and treatment scheme for pcSILAC is described in
detail in Figure 1 and Figures S1-S2. Briefly, two cell cultures to be
compared are fully labeled with, respectively, ‘‘medium’’ (13C6-L-
arginine, R6) and ‘‘heavy’’ (13C6
15N4-L-arginine, R10) Arg, while
Lys is left unlabeled (‘‘light’’, K0) for both. At the start of the
experiment, both cultures are transferred to new media containing
light Arg (R0) to perform the chase of R-labeled pre-existing
proteins. In turn, the new media contain, respectively, ‘‘medium’’
(‘‘M’’, 2H4-Lysine, K4) and ‘‘heavy’’ (‘‘H’’,
13C6
15N2-L-lysine, K8)
Lys, which will label all newly synthesized proteins for the pulse
measurements. At the same time or after medium exchange, one
of the cultures is subjected to a perturbation (here, drug
treatment). Extracts from control and drug-treated cells are then
harvested at defined time points, mixed equimolarly, digested with
trypsin and analyzed.
One peculiarity of the pcSILAC labeling scheme is that, unlike
in standard SILAC, Arg (R) and Lys (K) encode different
measurements, in this case the chase and the pulse, respectively.
Therefore, the quantitative information provided by peptides
containing labeled K or R is different and has to be kept
separate at the protein level. From the triplex isotope patterns
observed in pcSILAC six ratios (Figure 1) are derived for every
protein at each time point. The most directly interpretable
ratios are the ‘‘heavy’’ (H) over ‘‘medium’’ (M) ratios, (H/M)R
and (H/M)K. The (H/M)R (R10/R6) ratio describes the
evolution in time of the relative levels of pre-existing proteins,
because very little or no protein labeled with heavy or medium
R should be produced after medium exchange. Therefore, in
the final mixture the (H/M)R ratio at t.0 should mainly reflect
the relative decay rates of proteins in the treated vs. control
sample (Figure 1B). Simultaneously, as for ‘‘regular’’ pSILAC
measurements [31], the (H/M)K ratio should express the
relative levels of proteins newly synthesized and accumulating
in the two samples after medium exchange at t = 0 (Figure 1B).
Since newly synthesized proteins can also be subject to decay,
the (H/M)K (i.e. K8/K4) ratio is expected to reflect the
combination of changes in protein synthesis and in decay rates.
While the (H/M) ratios which are related to the comparison of
the two conditions are the easiest to interpret, the other
measured ratios (H/L) and (M/L) also carry information (e.g.
related to protein turnover) and can be exploited to derive other
parameters.
Experimental design and quality control of protein
labeling
Two independent pcSILAC experiments were performed
(Fig.S1), both of which included extraction and analysis of protein
at three time points (t = 6, 12, 20h). Experiment 1 also included a
standard SILAC control experiment using the same cells and with
quantitation only on Arg (H/M). As a quality control of the
labeling process, we inspected in detail the isotope envelopes of K-
and R-containing tryptic peptides and the replacement kinetics of
both labeled amino acids (Figures S1-S5). It appeared that label
replacement in time was complete, resulting in minimal mixing of
old and new label. We could also determine that i) mixed-labeled
peptides containing both K and R were unsuitable for quantitation
and that ii) a slight difference was present in the (H/L), resp. (M/
L) ratios measured on K- vs. R-containing peptides, which had to
be accounted for in further steps (see supplementary information
S1).
Coverage and reproducibility of pcSILAC data
Due to the triplex labeling (each peptide is present as 3 peaks),
the rejection of mixed-labeled peptides and the separation of K-
and R-based quantitation, pcSILAC experiments typically resulted
in lower proteome coverage than comparable (duplex) stSILAC
measurements. While more than 3400 proteins were identified in
the samples in pcSILAC experiments 1 and 2, after stringent
filtering respectively only 539 and 911 proteins quantified with all
6 ratios at all three time points were retained for further
calculations. As an indicative comparison, a similar (but duplex)
stSILAC experiment resulted in 2695 proteins quantitated at two
time points in three replicates (Fierro-Monti et al., accompanying
manuscript). Reproducibility between pcSILAC experiments was
assessed at 20h on various ratios. Values of Pearson’s correlation
coefficient r between medians of replicates of experiments 1 and 2
were generally above 0.85, indicating good reproducibility (figures
S1, S6).
Reference stress proteins and Hsp90 clients show
expected trends in pcSILAC data
As described above, the ratios (H/M)R and (H/M)K are the
most directly interpretable pcSILAC data. These ratios reflect a
direct comparison of the relative protein abundances in the treated
(heavy labeled) to the untreated (medium labeled) cell cultures.
Again, the (H/M)R (i.e. R10/R6) ratio measures the relative levels
of pre-existing protein remaining at time t (Figure 1B). By contrast,
the (H/M)K (i.e. K8/K4) ratio reflects the relative levels of
proteins newly synthesized and accumulating from t = 0 until time
t. We selected some reference proteins with known behavior
following Hsp90 inhibition in order to validate qualitatively
pcSILAC data. Cytosolic Hsp90 proteins (Hsp90a; HSP90AA1
and Hsp90b; HSP90AB1) as well as Hsp40 (DNAJB1) and Hsp47
(SERPINH1) are among the stress response proteins whose levels
increase by transcriptional activation upon GA treatment as well
as heat shock [41] [51]. Quantitation of transcripts confirmed that
the mRNAs for these and other chaperones were increased in GA-
treated cells (Fierro-Monti et al., accompanying manuscript).
Consistent with their known mechanism of change, these and
several other chaperones displayed (H/M)K ratios greater than 1
(log2 values positive) together with (H/M)R ratios close to 1 (log2
values near 0), indicating increased net protein synthesis in GA-
treated cells, with only small (but sometimes significant, see below)
changes in protein decay (Fig.2A-C). For these increasing
chaperones, the increase in newly synthesized protein seems to
drive the rise in total level observed in GA-treated cells (Fig.2C).
Pulse-Chase SILAC for Protein Synthesis and Decay
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Figure 2. Raw and normalized (H/M)K, (H/M)R ratios measured in pcSILAC experiments. A),B) Scatter plots of global ratios of pre-existing
protein ((H/M)R) and newly synthesized protein ((H/M)K) after correction for mixing ratio and normalization around the median. Values shown are for
pcSILAC experiment 1 (average of two replicates) at t = 6h (A) and t = 20h (B). Reference (red) and other proteins discussed in the text (blue) are
indicated. C) Evolution in time after start of GA treatment of normalized ratios of total protein (stSILAC, blue), newly synthesized proteins ((H/M)K,
green) and pre-existing protein ((H/M)R, red). Data points refer to values at t = 6,12,20h after addition of GA (t = 0). pcSILAC ratios were normalized (i.e.
centered around population median) to facilitate comparison with changes in total protein levels. Fitting of the values for DNAJB1 to the model was
very poor due to its complex behavior, therefore decay and synthesis rates could not be calculated for this early induced protein. D) Box plots
(experiment 1) of global log2(H/M)K and log2(H/M)R ratios after mixing ratio correction but before normalization E) same as D), but values are shown
after correction for mixing ratio and normalization.
doi:10.1371/journal.pone.0080423.g002
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As reference proteins for the detection of decay we choose the
protein kinases LCK, CDC2 ( = Cdk1) and CDK6, known Hsp90
‘‘clients’’ that are increasingly degraded upon Hsp90 inhibition
[52–56]. Consistent with these previous reports, all three proteins
displayed negative log2(H/M)R values, suggesting an increased
decay of the pre-existing protein pool in GA-treated cells (Fig. 2A-
C). Not unexpectedly, the amount of newly synthesized protein
was even more strongly affected by GA and showed a sharp
decrease. For LCK, both findings are consistent with the results of
Yorgin et al [57] who showed an impact of Hsp90 inhibition on
both mature and newly synthesized forms of the kinase, with a
stronger reduction in levels of the latter. From the values for these
reference proteins we concluded that, at least qualitatively,
pcSILAC measurements can reveal both changes in protein decay
and protein synthesis rates.
Distributions of pcSILAC ratios hint at global changes in
proteome turnover
In pcSILAC, as in general in SILAC, approximately equal
amounts of total proteins extracted from control and treated cells
were used for the experiments. Each pcSILAC cell extract sample
was constituted of pre-existing proteins (with "old" label) and
newly synthesized proteins (with "new" label) in unknown
proportions. The (H/M) pcSILAC ratios directly compare
between conditions the amounts of pre-existing ((H/M)R) and
newly synthesized ((H/M)K) proteins. Therefore, the distribution
of raw (not normalized) values of these ratios can potentially give
information on changes in global protein turnover caused by the
treatment. A comparison of the distributions of (H/M)R and (H/
M)K raw ratios before normalization revealed that the population
of (H/M)K ratios – measuring newly synthesized proteins, with H
being the treated (GA) and M the control (DMSO) sample -
consistently showed lower values than the one of pre-existing
protein ratios ((H/M)R) (Fig. 2D-E, Figure S8). This implies that
the global ratio of new over pre-existing protein was different in
the two samples. More specifically, with the same amount of total
protein the treated sample contained less newly synthesized
protein and more pre-existing protein than the control sample,
and the differences increased with time, suggesting global changes
in protein synthesis and/or decay induced by the inhibitor. The
second global observation was that (H/M)R ratios showed in all
replicates and at all time-points a much narrower distribution than
(H/M)K ratios (Fig. 2D-E, Fig. S7 and S8). This suggests that, at
least globally, Hsp90 inhibition had a bigger impact on the levels
of newly synthesized proteins than on those of pre-existing
proteins. These two global observations and their functional,
biological implications are discussed more in detail below and
elsewhere (Fierro-Monti et al., accompanying manuscript).
The relationship between pcSILAC ratios and net protein
levels (standard SILAC ratios) is complex
pcSILAC can measure the ratios of levels of pre-existing ((H/
M)R) and newly synthesized proteins ((H/M)K), respectively in the
treated (H) vs. control (M) cells. The relationship between the
values of these ratios and the change in total protein levels can be
expected to be complex, due to the combination of effects on
synthesis and decay. For strong changes in (H/M)R and/or (H/
M)K, such as those observed for the reference proteins discussed
above, a net protein increase (HSP90AA1( = Hsp90a), DNAJB1),
and respectively a decrease (LCK, CDK6, Cdk1) can be
confidently predicted. Correlating pcSILAC data with net protein
changes appears less straightforward for proteins whose values of
(H/M)R and (H/M)K indicate contrasting trends, such as a
decrease in stability coupled with a higher synthesis (PTGES3, the
Hsp90 cofactor p23) or a stabilization with lower synthesis
(POLR2). A global representation of the stSILAC ratios versus
(H/M)R and (H/M)K ratios, from a stSILAC control prepared
within the same experiment as the pcSILAC, suggested indeed
that for a similar net protein change (stSILAC), different proteins
can display different combinations of (H/M)R and (H/M)K (Fig.
S9). We addressed the complex relationship between (H/M)R and
(H/M)K and stSILAC (H/L) ratios through a mathematical
treatment, whose steps are described below and in the supple-
mentary information.
pcSILAC data can be used to calculate net protein
changes
Given the pcSILAC labeling scheme, each protein is expected
to be present as 4 differently labeled species, represented by the
four variables U, V, X,Y:
U~PR6 K0
V~PR0 K4

in culture A (DMSO and
X~PR10 K0
Y~PR0 K8

in culture B (GA) (1)
Thus U and X represent the amounts of proteins synthesized
before label exchange, while V and Y those produced after label
exchange. In turn, U, V, X,Y are related to the measured pcSILAC
ratios by simple algebraic relationships such as (H/M)R =X/U
and (H/L)R =X/(Y+V). From these, it is possible to obtain the
incorporation ratio, i.e. the ratio ‘‘new label’’/‘‘old label’’, at a
given time point. More importantly, we could show that it is
possible to calculate from pcSILAC data the net ratio S~
XzY
UzV
(equivalent of a stSILAC ratio) for any protein at a given time
(supplementary information S1). The derived values of S were
found to be in very good correlation (Fig. S10) with experimental
values obtained from an ‘‘internal’’ stSILAC replicate for
pcSILAC experiment 1 (Pearson’s r = 0.94), as well as with ratios
from an external stSILAC experiment (Pearson’s r = 0.91, Fierro-
Monti et al., accompanying manuscript). The possibility to obtain
accurate net protein changes from pcSILAC ratios was an
important internal control and showed that the pcSILAC data
correctly reflect the changes occurring in the system.
Model development and calculation of kinetic
parameters
Having verified the reproducibility and representativeness of the
data, we developed a mathematical model to calculate kinetic
parameters for large numbers of proteins from pcSILAC data. The
model used to describe the evolution of protein concentrations in
control and treated cells was based on the following assumptions: i)
before the beginning of the experiment (t = 0) the two cultures are at
steady state and thus have identical concentrations of all proteins
which remain constant in time; during the experiment (t.0) only
the control culture keeps the same steady state ii) the system can be
described by first-order rate decay and synthesis terms; iii) kinetic
parameters of proteins change much faster than the protein
concentrations when drug is added to cultures at t = td, and remain
constant thereafter (hence the change of these kinetic parameters is
assumed instantaneous on the scale of the experiment) iv) the total
global protein concentration in the cell is the same in both cultures
and remains constant during the experiment (only the relative
abundances of individual proteins vary between the cultures); v)
each protein is present in the cell as a homogeneous pool, whereby
the synthesis and decay rate constants are only dependent on the
protein species and not the protein localization or folding state.
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In order to describe the evolution of the protein concentrations
in the cell, we adopted a standard ordinary differential equation
(ODE) which is often been used for such purposes [58,59]. This
equation is directly derived (see supplementary information S1)
from the mass balance equation, and describes for example the
evolution of the concentration of a protein p in sample A as:
dpA
dt
~VA{(kA,dzmA):pA~VA{kA,app:pA ð2Þ
where VA and kA,d are, respectively, the synthesis rate and the
decay rate constant for the protein pA; mA corresponds to the cell
growth rate and is accounting for the dilution of proteins, and
kA,app is an apparent decay rate, defined as
kA,app~kA,dzmA ð3Þ
The same equation (2) can be used to describe the evolution of
concentrations in sample B (treated cells). It is important to note
that, while the control sample A is assumed to be at steady-state
with constant protein concentrations, the treated sample B is a
non-equilibrium system which evolves toward a new steady-state
during the experiment, and as such possesses more degrees of
freedom.
Based on the fundamental equations (1) – (3), it was possible to
derive and solve ODE’s for the four variables u, v, x and y
(obtained from U,V,X,Y after normalization for unequal mixing of
protein extracts), thus obtaining analytical expressions describing
the evolution of the system as a function of time (u(t), v(t), x(t), y(t)).
Then these equations were used to determine the kinetic
parameters by fitting the equations to the data. For the fitting,
additional corrections were performed to account for sample
mixing ratios and trypsin cleavage efficiencies differences (supple-
mentary information S1). Several steps of fitting were then used to
first determine some global coefficients for the correction factors
and then the kinetic parameters for each protein (see Figure 3 for a
flow chart of the computational method and supplementary
information S1). An implementation of this procedure into
MATLAB is available upon request to J. Racle and V.
Hatzimanikatis. Importantly, the quality of the fitting and
convergence of the data were monitored and only proteins with
data fitting the model well were retained, which was the case for
most of proteins (Figure S12). However, a small set of proteins,
among which DNAJB1 (Fig. 2C), consistently showed a complex
multi-phasic evolution in time which could not be appropriately
accounted for by the model (Fig. S16). Kinetic parameters could
therefore not be calculated for these proteins.
The first output of the calculations (Table S4) is the apparent
degradation constants for proteins in the control and drug treated
cells, kA_app and kB_app. The real ‘‘specific’’ degradation constants
kA,d and kB,d can be deduced from these through a correction
considering the growth rate (equation (3) and supplementary
information S1). kA,d and kB,d can be used to calculate protein half-
lives in both the control and the treated cells. The second main
output of the calculations is the ratio of synthesis rates VB/VA.
From the obtained values of kA,d and kB,d and VB/VA, it is possible
to calculate directly the expected steady-state (with tR‘) ratio of
net protein concentrations pB/pA. Furthermore, we integrated in
our workflow information on pseudo-absolute protein amounts
calculated with intensity based absolute quantification (iBAQ)
scores and used it to infer values for VA, VB, pA, pB in arbitrary
units. Finally, we calculated changes in fluxes of synthesis and
decay induced by the GA treatment. Fluxes combine kd, V and the
dilution term m with protein concentrations and give the possibility
to compare the quantitative relevance of each kinetic term,
especially at early time points after the start of the perturbation
(t = td) (supplementary information S1).
Reference proteins display the expected changes in
decay constants and synthesis rates
Only protein groups with complete data, i.e. 6 ratios at 3 time
points, were used for calculations of kinetic parameters. Results for
experiment 2 (911 proteins) are presented here. Data for
experiment 1 (520 proteins) were overall very similar (Fig.S11-
S13). Plots of decay rate constants and relative synthesis rates in
the two conditions (Figure 4A, B) showed that the reference
proteins CDK6, LCK, CDC2, HSP90AA1, HSPA8 (HSC70)
displayed the expected patterns, with significant increases in the
decay rate constants for the three kinases and increases in relative
synthesis rates upon drug treatment for the two considered
chaperones. In addition to showing some of the fastest decays in
absolute terms, CDK6, LCK, and CDC2 also displayed decreased
synthesis rates. Only a few meaningful comparisons can be done
with published data, since most determinations of kinetic
parameters so far have been purely qualitative or done in different
conditions. Yorgin et al. [57] reported that treatment with 1.7mM
GA increased approximately 2-fold the decay rate of mature LCK
over a period of 24h. We detected an increase of a factor 5 in
decay rate for pre-existing LCK.
Decay rate constants at steady state: distribution and
correlation with other studies
The determination of absolute values for decay rate constants in
control cells (kA,d) allowed us to carry out comparisons of protein
half-lives for steady-state cells with values reported previously
[32,35,58]. After matching corresponding proteins by gene name,
half-lives (T1/2) of protein groups from experiment 2 showed no
significant correlation with the three published datasets, with
Pearson’s r values between 0.014 and 0.065 (Fig. S14). It should be
noted that cell types and organisms used in these studies were very
different. In spite of this lack of direct correlation the overall
distribution of half-lives in our data was similar to that measured
by two of the other studies (figure S14), with similar medians (55.8
h in our data vs. 47.3 h for Wu et al. [32] and 47.8 h for
Schwanha¨usser et al.[58]). Annotation enrichment analysis per-
formed on kA,d values indicated that proteins involved in cell cycle
and transcription as well as nuclear, DNA-binding and signaling
proteins had higher than average degradation constants, i.e. high
turnover (unstable proteins) (Table S5). Conversely, proteins
participating in core metabolic pathways such as glycolysis,
glucose catabolism, amine and alcohol metabolism had globally
low kd’s (stable proteins). Heat shock proteins and Hsp90
cofactors, i.e. proteins that coadjuvate Hsp90 in the binding and
folding of substrates, too, were very stable, long-lived proteins.
Results from annotation enrichment analysis were thus qualita-
tively in good agreement with previously reported ones [58], and
this despite the general lack of correlation at the individual protein
level. This suggests that globally protein stability is a conserved
feature, at least at the level of protein families.
Hsp90 inhibition causes a global increase in decay which
also affects chaperones and Hsp90 cofactors
We next analyzed the changes induced by drug treatment on
decay rate constants kd’s. The median of the GA/DMSO ratio of
the apparent decay rate constants kB_app/kA_app was 0.75, but after
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correction for cell growth, decay appeared to be globally higher in
drug treated cells with a median for kB,d/kA,d of 1.74 (1.55 in exp.1)
(Figure 4C). Nevertheless, results of annotation enrichment analysis
for decay in treated cells (kB,d) were overall similar to those for control
cells (kA,d). This was in line with the overall distribution of kB,d values
(Figure 4A) which shows that, relative to the overall population, the
drug caused strong changes in decay for only a few proteins.
Interestingly, two categories that were found to have increased
degradation upon drug treatment were those of Hsp90 cofactors
(defined as in www.picard.ch/downloads) and generally heat shock
proteins (defined as described [43]), although within these categories
the behavior varied significantly from protein to protein.
Hsp90 inhibition results in a global shutdown of protein
synthesis, while stress proteins are strongly induced
Analysis of the ratios of synthesis rate VB/VA (GA/DMSO)
showed that globally, synthesis rates were clearly decreased in
drug-treated cells, with a median value for VB/VA of 0.58
(Figure 4B,C) (0.55 in exp.1). Annotation enrichment analysis
for the parameter VB/VA highlighted the increased synthesis of
stress-related polypeptides, i.e. chaperones, folding proteins and
Hsp90 cofactors (Table S5). Other terms with increased
synthesis were ER proteins, components of the N-linked
glycosylation machinery, cytoplasmic vesicle proteins and
subunits of the proteasome. Among proteins with decreased
Figure 3. Computational workflow for the determination of kinetic parameters kd and VB/VA from pcSILAC data. The individual steps
of the computational workflow are described in detail in the supplementary information S1. Briefly, (1) using the total peak intensities (similar to iBAQ
scores), the global mixing ratio between both samples is computed. (2) The equations describing the evolution of the protein concentrations in the
cells are converted into equations describing the evolution of the protein abundances using the mixing ratio values. (3) These equations can then be
used for a global fit of the experimental data for multiple proteins at the same time. (4) The global fit results in estimates for the coefficients
describing the peptide cleavage rates (or efficiencies) - these coefficients are then set to be identical for all protein species. (5) The estimates of the
cleavage efficiencies are inserted into the model describing the evolution of protein abundances in the samples; the experimental data from each
protein species can then be fitted, for each protein species independently. (6) Instead of directly doing these fits to the experimental data, some
random artificial noise is added through a bootstrap-like method - this increases the confidence in the results (as noise cannot be avoided in the
experimental measurements, and we repeat the fit with various simulated noise values to compare the outcomes). (7) The fit of the model to the
bootstrapped data results in one set of estimates of synthesis and degradation rate constants for the normal and drug-treated conditions for each
protein. (8) The final estimates are the average values from the different estimates that were obtained by repeating the fitting step multiple times
with different bootstrapped data values for each protein species.
doi:10.1371/journal.pone.0080423.g003
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synthesis, the terms enriched comprised ribosomal and rRNA
processing proteins as well as components of the purine and
pyrimidine metabolic pathways.
The theoretical new steady state is not reached in the
course of the experiment
With a shift of the apex towards negative values, the
distributions of net protein ratios (Figure 4D) illustrate the general
evolution of the system, which sees the decrease of many proteins
likely compensated by the increase in concentrations of a few
abundant proteins, namely chaperones and stress proteins. From
the decay constants kA,d, kB,d and the synthesis rates VB/VA values
we derived the steady-state ratio of net protein concentrations pB/
pA, which corresponds to the expected state of the system at the
end of its evolution (with t = infinite). pB/pA showed a good but
not extremely high correlation (Pearson r = 0.709) with the
calculated net protein ratio at 20h obtained as the S ratio. A
comparison of the distribution of net protein ratios calculated at
the three time points with the expected final steady state
Figure 4. Results from calculations of decay constants, synthesis rates and evolution of total protein levels. Indexes of variables are A
(as in kA, VA) for control (+DMSO) and B (as in kB, VB) for treated (+GA) cells. A) Scatter plot of the values of the degradation constants for the control
and treated sample (experiment 2, 911 proteins). The position of reference proteins is indicated. The dashed line indicates a 1:1 relationship B) Scatter
plot of VA and VB (same dataset as A). Other heat shock proteins are shown in pink. The dashed line indicates a 1:1 relationship C) Kernel density
estimate of log2 of ratios of synthesis rates (VB/VA) and degradation constants (kB,d/kA,d) after correction for cell growth. D) Comparison of
distributions of log2 of ratios S of net protein levels (treated/control) calculated from pcSILAC data at t = 6, 12, 20h vs. ratios at steady-state
(t = infinite) calculated from the model. S values were corrected for mixing inequalities.
doi:10.1371/journal.pone.0080423.g004
Pulse-Chase SILAC for Protein Synthesis and Decay
PLOS ONE | www.plosone.org 10 November 2013 | Volume 8 | Issue 11 | e80423
concentrations pB/pA shows the increasing divergence of the
control and treated samples in time, but also suggests that at t
= 20h the system has not reached the steady state predicted by the
model (Figure 4D). Whether the cells, given more time, would
actually reach this theoretical new steady state is unclear. The
evolution of ratios for some early induced proteins (e.g.
DNAJB1 = Hsp40) (Figure 2C) could suggest that the GA-treated
cells at t = 20h have started at least a partial recovery towards the
basal state.
Proteins and protein families show distinctive changes in
decay and synthesis rates
A global representation of the observed changes in kinetic
parameters (Figure 5A) shows how changes in decay rate constant
(k,d) and synthesis rates (VB/VA) combined to determine net
protein changes at 20h (color gradient). Among proteins that show
a net decrease in abundance, two groups seem to appear. The first
one (I) includes CDK6 and LCK and is characterized by a strong
increase in decay accompanied by a decrease in synthesis. A
second group (II) shows a decrease in synthesis with little or no
change in decay rates. The model predicts that the levels of group
II protein would be expected to further decrease strongly at later
time points. Whether this actually happened, would remain to be
established. We explored the changes in decay and synthesis
parameters for some protein families relevant to cellular
proteostasis (Figure 5B). Ribosomal proteins had synthesis rates
that decreased more than the general population, although they
also appeared to be somewhat stabilized in the presence of GA.
The overall result was a net decrease (median of log2(S) = -0.18 at
20h) and a decreased turnover. Subunits of the proteasome were,
in relative terms, more synthesized in GA-treated cells, with no
visible overall trend at the level of decay. The result was an
average mild increase in their net levels (median of log2(S) =
+0.104 at 20h) compared to untreated cells. The changes in net
levels for these two categories of proteins were confirmed by
standard SILAC analysis (Fierro-Monti et al., accompanying
manuscript) and correlated well with the global decrease in protein
synthesis and increase in degradation observed. Figure 5B also
shows that heat shock proteins were among the most increasingly
synthesized molecules in GA-treated cells, but intriguingly their
decay rate ratios kB/kA were often above average, indicating
specifically increased turnover. Protein kinases constitute the most
prominent class of known Hsp90 clients. Only 19 protein kinases
were fully quantified in our pcSILAC experiments, most probably
due to their low levels of expression and the limited proteome
coverage obtained. Out of these, 6 (LCK, CDC2, CDK6, STK39,
ZAP70, CSK) clearly showed increased decay or and/or
decreased synthesis, while the remaining 13 kinases behaved
roughly like the bulk of the proteome. Although the number of
kinases quantitated by pcSILAC is low, the trend is in agreement
with recent data suggesting that only about one third of the
kinome decreases upon Hsp90 inhibition [32] or again that only
about one third of all kinases binds with high affinity to Hsp90
[60]. A more detailed analysis of the patterns of changes observed
for various families and functional classes of proteins is presented
elsewhere (Fierro-Monti et al., accompanying manuscript).
Changes in synthesis rates play a bigger role than
changes in decay in shaping the proteome after
perturbation
We then tried to ascertain the overall contribution of protein
stability, its changes compared with changes in synthesis rates, to
variations in net protein levels. Decay rate constants in control
cells (kA,d) had a moderate inverse correlation with changes in net
protein levels (r = –0.21 for exp.1, against stSILAC ratios from
internal control at 20h) (Fig. S15), suggesting that intrinsically
unstable proteins had a certain tendency to be depleted more than
stable ones upon Hsp90 inhibition. This finding is in agreement to
what was reported previously for protein kinases [32]. However,
changes in protein synthesis induced by GA, i.e. VB/VA,
correlated much stronger than decay rates kA,d with changes in
net protein levels (r = 0.82 for exp.1, against internal stSILAC
values, Fig. S15). Density plots of changes in decay and synthesis
kB/kA and VB/VA (Figure 6A, B) for sets of decreasing, increasing
and invariant proteins at t = 20h confirmed that overall net
changes in abundance correlated strongly with changes in
synthesis (VB/VA values) and only weakly with changes in decay
(kB,d/kA,d). To better quantitate the relative contributions of
variations in synthesis and decay, we calculated total changes in
fluxes (DW) of synthesis and decay (see supplementary information
S1). Fluxes give a measure of actual, instantaneous ‘‘flow’’ of
molecules, taking also protein concentration into account. The
global values obtained for the whole population early during drug
treatment were DWsynthesis = –44.0 [a.u. x h
21] and DWdegradation =
–24.8 [a.u. x h21]. The bigger absolute value of DWsynthesis further
supported the view that, although the changes due to variations in
decay are not negligible, those due to changes in synthesis are
quantitatively more important. More specifically, it indicates that
even for proteins that decrease in net concentration, their decrease is
(on average) due more to a decrease in synthesis than to an increase
in decay.
Discussion
Quantitative proteomics techniques measure differences in net
protein levels in complex mixtures such as whole cell extracts.
Interpretation of datasets derived from such experiments is
challenging, not the least because the underlying mechanisms
that direct the changes in protein concentration are not
immediately apparent from the final net changes. We developed
pcSILAC in an attempt to shed light on the variations in synthesis
and decay rates that determine final protein levels in a perturbed
cellular system. We aimed at comparing two conditions directly in
the same experiment and this posed major challenges for the
design of the labeling scheme. A minimum of four channels was
needed to measure two biological conditions each with the two
labels (before/after medium exchange) corresponding to the pulse
and chase experiments. Standard SILAC is limited to three
channels and is thus insufficient. Multiplexing beyond three is
difficult and risky, considering that triplex labeling already results
in sometimes very complex, overlapping isotope patterns. We
chose to separate the quantitation obtained with the two SILAC
amino acids, to gain additional measurement channels. This
allowed us to design a labeling scheme in which two biological
samples were directly compared to each other in the MS
measurements.
Boisvert et al. [35] developed and used a different strategy for
measuring synthesis and degradation in a steady-state system,
which uses a reference sample corresponding to the initial
proteome against which the pulsed/chased signals are compared
in a standard triplex SILAC configuration. The approach of
Boisvert et al. could be expanded to measure two biological
conditions separately in two distinct experiments. The disadvan-
tage is that this would require doubling the already considerable
necessary instrument time and performing the comparison in an
indirect manner. Another labeling strategy has been reported
recently in a study focusing on the effects of inhibitors of the
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mTOR complexes [61]. In this study however, the determination
of decay and synthesis was based on separate experiments and the
different kinetic parameters were not integrated in a comprehen-
sive model. Also very recently, Troetschel et al. [62] proposed a
different approach based on 15N and 13C for labeling of bacteria
and were able to determine, with two different experiments,
degradation and synthesis for a few hundreds of proteins in two
conditions. Compared with both the schemes of Boisvert et al and
Troetschel et al [62], the main advantage of pcSILAC is that it can
measure both conditions together in the same experiment. The
trade-off is that the proteome coverage that can be obtained by
pcSILAC is, at parity of instrument time, reduced relative to
simpler SILAC experiments because of the separation of
quantitation in R and K channels and the exclusion of mixed-
labeled peptides.
In pcSILAC, the first level of analysis is the direct comparison
of the amounts of pre-existing and newly synthesized proteins
through the (H/M)R and (H/M)K ratios. This was important to
perform as a first level of evaluation and verification on raw
data upstream of the complex mathematical data processing. It
also allowed a preliminary qualitative analysis of relatively large
numbers of proteins at single time points, without the
restrictions imposed by the kinetic parameter calculations which
require having data for three time points per each protein.
pcSILAC data however contain more information than just the
(H/M)R and (H/M)K ratios. For example, the possibility to
easily calculate pseudo-stSILAC ratios (S) from pcSILAC data
was crucial for a quality control of the experiment and for
establishing correlations between kinetic parameters and
changes in net protein levels. Also, thanks to the partial
redundancy of the data, robust fittings were obtained when all 6
ratios were used for obtaining kd and V values, likely because
possible inaccuracies in one value were compensated by other
ratios available.
Compared to stSILAC experiments, pcSILAC can provide
several unique levels of information. First, the possibility to
distinguish newly synthesized from pre-existing proteins and to
compare these two pools between the two samples gives the
possibility to detect changes in global protein metabolism. In the
model system of Hsp90 inhibition, pcSILAC revealed an
important reduction of the global protein synthesis rate, not
unexpected in stressed cells. Such reduction in synthesis is
associated with (and may be one of the causes of) the observed
cell cycle arrest. Simultaneously, the observed increase in overall
degradation could stem from defects in the folding machinery.
Similar changes in synthesis and degradation are undetectable in
standard quantitative proteomics experiments in which normali-
zation by protein amount destroys the possibility to capture
variations e.g. in total protein content of the cell or in general
protein turnover.
Figure 5. Changes in degradation and synthesis rates induced by Hsp90 inhibition and relationship with changes in net total
protein levels and protein families. Indexes of variables are A (as in kA, VA) for control (+DMSO) and B (as in kB, VB) for treated (+GA) cells. A)
Scatter plot of the values of ratios of intrinsic degradation constants kB,d/kA,d vs. the ratios of synthesis rates VB/VA. The median values of kB,d/kA,d and
VB/VA for the population are indicated with dashed lines. Coloring of points is according to the calculated treated /control total protein ratio at t = 20h
(ratio S). B) Same as A) but with coloring of ribosomal, proteasome and heat shock proteins. Groups I and II are discussed in the main text. All values
are log2.
doi:10.1371/journal.pone.0080423.g005
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Furthermore, the possibility to derive true decay rate constants
kd for both the control and treated cells allowed a real evaluation
of intrinsic protein stability in both control and treated cells, while
until now the determination of kd’s and half-lives was limited to
steady-state cells. For the system under study, the determination of
synthesis rate ratios VB/VA, together with the knowledge of decay
rate constants (kd’s), allowed a comprehensive assessment of the
factors that determine net protein changes. Compared with the
raw (H/M)R, (H/M)K ratios, decay rate constants kd and synthesis
rate ratios VB/VA have an improved information content since the
synthesis and decay terms can be separated and analyzed
individually. For example, it was possible to establish that
CDK6 is among all the quantitated proteins, the one with the
largest absolute decrease in stability upon Hsp90 inhibition, but
that its apparent synthesis rate is also diminished, although less
than other proteins. Conversely, numerous other polypeptides are
only affected at the level of synthesis (group II in Figure 5A),
whereas their stability is almost unchanged. Indeed, the results
from pcSILAC would suggest that, apart from a general moderate
increase in decay, changes in stability following Hsp90 inhibition
affect only a limited subset of the proteome, while the largest net
changes in protein levels can be ascribed to modulation at the level
of synthesis. A very important caveat is, however, that the model is
assuming that one single pool of each protein exists in the cell,
which decays and is synthesized in a homogeneous fashion.
Paradoxically, Hsp90 inhibition may be one case in which this
assumption only partially holds true. It has indeed been shown
[39,63] that many Hsp90 ‘‘clients’’ that are depleted in the
presence of GA are indeed being synthesized but are immediately
targeted for proteasomal degradation likely because their folding
cannot be completed. Such a pool of protein would not be
subjected to the same decay rate as the bulk of pre-existing (and
presumably mostly correctly folded) protein and would appear in
pcSILAC as reduced synthesis rather than increased decay. It is
therefore likely that the synthesis rate (V) values measured by
pcSILAC for a number of direct Hsp90 clients are distorted by co-
translational degradation. A further dissection of translation and
early post-translational events would require use of protein
synthesis- or proteasome inhibitors, which however would result
themselves in major perturbations of proteostasis, raising further
questions on the relevance of the data obtained. An exciting option
for future studies would be the measurements of ubiquitination
levels [64], whereby it must be kept in mind that ubiquitination
does not always result in proteasomal degradation. Moreover, the
assumption that each protein behaves as a homogeneous cellular
pool is clearly an oversimplification, especially for eukaryotic cells.
More in-depth analyses by pcSILAC should therefore aim at
separating and analyzing subcellular compartments as previously
done for steady-state cells [65,66].
Technically, the pcSILAC strategy could be improved at several
levels. Measurements of samples at more than three time points
could significantly improve the fitting of the kinetic parameters.
The number of samples that can be analysed is, however, limited
by the mass spectrometer time needed, which can be quite
important for complex proteomes. Another critical point of
pcSILAC – which is common to any approach for the
determination of kinetic constants – is the need to measure
accurately cell growth in the two biological conditions. The
correction for growth does indeed have a major impact on the
absolute values of decay rate constants (kd’s) and inaccuracies in
cell counting can result in systematic biases in the final data.
Ideally, to reflect faithfully the cellular phenotype, sample loading
should be normalized by cell number instead of protein amount,
and counting of cells should be done in parallel with flow
Figure 6. Changes in degradation and synthesis rates in subsets of net decreasing, invariant and increasing proteins. Indexes of
variables are A (as in kA, VA) for control (+DMSO) and B (as in kA, VA) for treated (+GA) cells. Probability density functions of decay constant ratios kB,d/
kA,d (A) and synthesis rate ratios VB/VA. (B) are shown for the 10% most strongly increased proteins, the 10% most strongly decreased proteins and a
20% of proteins which were around the median of the concentration change (invariant proteins). The ratio of protein levels at steady-state (pB/pA
parameter) was used for the selection.
doi:10.1371/journal.pone.0080423.g006
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cytometry analysis to detect possible changes in size and shape of
cells upon treatment. It would then be possible to integrate e.g. cell
volume parameters in the mathematical model to provide more
accurate and representative results.
Last but not least, the model described here assumes that
protein synthesis and decay rates undergo a change at t = td and
then remain constant thereafter, converging towards a new steady-
state. Although in our data most proteins displayed an evolution
consistent with such a simple model, a few proteins had a more
complex behavior that could not be fitted properly, with e.g. a
quick increase in synthesis followed by a slowdown after 6h
(DNAJB1 in Figure 2C and others in figure S16). It is also
conceivable that other proteins could increase their synthesis only
after a lag time due to gene activation events. It remains to be
tested if such cases require a separate modeling or can be
integrated, through measurements of more time points, into a
single multiphasic model. A proper assessment of the observed
proteome changes would also need the monitoring of the
specificity of the Hsp90 inhibitor and of its stability both in the
medium and intracellularly during the duration of the experiment,
all aspects that have been often neglected in similar studies.
Finally, the full characterization of the system by pcSILAC was so
far possible for less than 1000 proteins, likely the most abundant
ones in the cell. A deeper exploration of changing proteomes –
which will require improvements in the technology and the
workflow - may reveal a larger variety of possible responses to a
given perturbation.
Supporting Information
Figure S1 Samples and conditions of standard and
pcSILAC experiments. Experimental design for pcSILAC
experiments; the yellow arrow indicates treatment with geldana-
mycin (GA) or DMSO. Correspondingly numbered replicates
were mixed (e.g. M1+H1, M2+H2) after total protein quantifica-
tion. For replicates M1 and H1 the treatment was inverted, i.e. H1
received DMSO while M1 was treated with GA. A) Experimental
design for pcSILAC experiment 1; coloured triangles indicate
medium exchange. The samples used as an internal standard
SILAC experiment in pcSILAC experiment 1 were derived from
the same culture used for pcSILAC labeling, therefore no medium
exchange was done and quantitation was performed only on R
(H/M). B) Same as A) for pcSILAC experiment 2 (no internal
standard SILAC replicate was done in this experiment).
(TIF)
Figure S2 Predicted and possible isotope peaks for
various classes of tryptic peptides in pcSILAC. A) Isotope
labeled amino acids used in the study and their monoisotopic mass
shifts relative to light amino acids B) General Labeling scheme for
pcSILAC with description of the isotopomers present in the media
before/after medium exchange (represented as a coloured triangle)
at t = 0 C) Possible isotope peaks of 1 x R- or 1 x K-containing
peptides after mixing H+L pcSILAC samples, with expected mass
shifts relative to a R0, resp. K0 peptide. D) Same as C) but for
peptides containing 2 K residues. The occurrence of mixed-label
peptides (*) during the phase of medium exchange was considered.
E) Same as D) but for peptides containing 2x R residues. F) Same
as D) but for peptides containing both 1 K and 1 R.
(TIF)
Figure S3 Differences in ratios measured for R- vs. K-
containing peptides. « Medium- » and « heavy » extracts from
cells at t = 6, 12 and 20h from pcSILAC experiments before
mixing were separated by SDS-PAGE. Fractions in the range 30–
150 kDa (A,B) or 60-100 kDa (C,D) were digested and analysed
by MS. For every protein, ratios were determined separately based
on K and R peptides. Data for a set of high-scoring proteins is
represented as scatter plots (one point per protein, non-log ratios).
All values plotted correspond to (new label)/(old label) ratios. (A)
DMSO-treated cells (M, L labeled) from pcSILAC experiment 1
(200 proteins) at 12h (B) Geldanamycin-treated cells (H,L labelled)
from pcSILAC experiment 1 at 12h (200 proteins). (C)-DMSO-
treated control cells (M, L labelled) from pcSILAC experiment 2
(80 proteins) (D) same as (C) but for GA-treated cells (H,L labeled).
(TIF)
Figure S4 Peptides containing both R and K in pcSILAC.
A) Isotope pattern observed for peptide GHYTE-
GAELVDSVLDVVRK (TBB2A_HUMAN) at t = 6h in the
H+L mix of pcSILAC experiment 1, replicate 2. The position of
possible peaks resulting from label mixing (old label + new label)
are indicated below the axis, with their expected mass shifts (see
figure S1) B) Same as A) but for peptide GVAINMVTEEDKR
(IF4A1_HUMAN) at t = 12h in pcSILAC experiment 1, replicate
1. Overall, the predicted isotope patterns for K+R-peptides were
observed. Peaks resulting from label mixing (old label + new label)
were sometimes detectable but had very low intensity (,3% of
base peak, marked below x-axis) compared to homogeneously
(old+old, new+new) labeled species. Spectra obtained for samples
before mixing were also inspected with similar results.
(TIF)
Figure S5 Isotope patterns observed for KK- or RR-
containing peptides in pcSILAC samples before mixing
(experiment 1, t = 12h). A) Isotope pattern observed for peptide
KVESLQEEIAFLK (MH+= 767.429, 2+, VIME_HUMAN) in
the "light" sample of pcSILAC experiment 1, replicate 2
(+DMSO). Location of possible isotope peaks resulting from label
mixing (old+new label) are indicated together with the expected
mass shift relative to the fully "light" peak. B) Peptide
IINEPTAAAIAYGLDKK (MH+= 894.4986,2+, HSP7C_HU-
MAN), "heavy" sample, replicate 2, (+GA). C) Peptide ARFEEL-
NADLFR (740.88112, 2+, HSP7C_HUMAN), "light sample,
replicate 2, (+DMSO) D) Peptide NLDIERPTYTNLNR
(580.304783, 3+, TBA1B_HUMAN), "heavy" sample, replicate
2 (+GA). Intensity of the mixed-labeled peptide peaks remained
below 5% of that of the newly synthesized peptide peak.
(TIF)
Figure S6 Correlation between pcSILAC datasets
(t = 20h) of different experiments. Scatter plots and Pear-
son’s r correlation coefficients for two pcSILAC experiments, each
with two biological replicates. After MaxQuant co-analysis, and
processing for K,R quantitation, datasets were filtered for a
minimum evidence count = 3. All ratios were normalized and
log2. (A) (H/M)R (B) (H/M)K (C) Same as (A),(B) but replicates for
each experiment were averaged before plotting and calculating
inter-experiment correlations. (D) (H/L)R ratios for the same
replicates, showing that R-based ratios, too can highly correlated
between replicates and experiments. Note: the low values of the r
coefficient obtained for (H/M)R can be explained with the very
small spread of the (H/M)R values, i.e. the fact that most values
are very close to 1 and therefore the correlation is strongly
influenced by noise, which tends to be constant and random.
(TIF)
Figure S7 Reproducibility of values of (H/M)K,(H/M)R
ratios for reference proteins and evolution in time in two
pcSILAC experiments. Normalized ratios are shown. A)-C)
pcSILAC experiment 1, D)-F) pcSILAC experiment 2. DNAJB1
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= Hsp40; HSP90AA1 = Hsp90alpha; HSP90AB1 = Hsp90beta;
PTGES3 = p23; PRAKAR1A = regulatory subunit of Protein
kinase A; POLR2A = DNA-directed RNA polymerase II subunit
RPB1; EEF2 = Elongation factor 2; CDC2 = Cyclin-dependent
kinase 1; LCK = tyrosine protein kinase LCK; CDK6 = cyclin-
dependent kinase 6.
(TIF)
Figure S8 Global distribution of (H/M)K, (H/M)R ratios
measured in pcSILAC experiments 1 and 2. Boxplots of
global (H/M)K, (H/M)R ratios for replicate 1 of pcSILAC
experiment 1, (yellow), replicate 1 of experiment 2 (blue), replicate
2 of experiment 2 (green), replicate 2 of experiment 2 (pink). ‘‘R’’
stands for (H/M)R, ‘‘K’’ for (H/M)K. A), C), E), G) show values
after correction for mixing ratio only. B), D), F), H) show values
after correction for mixing ratio and normalization. Ratios were
inverted whenever necessary to facilitate comparison between
replicates with inverse treatment.
(TIF)
Figure S9 (H/M)K, (H/M)R ratios from pcSILAC exper-
iment 1 (t = 20h) and their relationship with stSILAC (net
protein) values. The values of (H/M)K, (H/M)R (median of two
replicates ) at t = 20h are represented as scatter plot, with color
coding according to the medians at t = 20h obtained for the same
protein from an internal (carried out simultaneously, with the same
cells ) stSILAC experiment. A degree of correlation is observed,
stronger between (H/M)K and standard SILAC values. However,
similar values in std SILAC experiments can correspond to
different combinations of (H/M)K, (H/M)R values.
(TIF)
Figure S10 Calculation of a net protein ratio S from
pcSILAC data and correlation with net protein ratios
determined experimentally through independent exper-
iments. A) Correlation between theoretical S1 and S2 values (from
pcSILAC data) obtained with two complementary equations (eq.5
and eq.6 in main manuscript) using different ratios. Data were from
replicate 2 of experiment 1, not corrected for mixing ratio
inequalities. B) Correlation of S (calculated as average of S1, S2,
normalized) with experimental standard SILAC (net protein) ratios
from a parallel experiment performed simultaneously (« internal »
control) or C) an independent standard SILAC experiment
performed 6 weeks earlier. Log2 have been applied on median-
centered values of ratios. Data are from pcSILAC experiment 1.
(TIF)
Figure S11 Results from calculations of of kinetic
parameters for pcSILAC experiment 1 (same plots as
in main Figures 4–5, other experiment). A) Scatter plot of
decay rate constants for the control and treated sample
(experiment 1, 520 proteins). The position of reference proteins
is indicated. B) Scatter plot of Vs_control and Vs_treated in the
same dataset. Other heat shock proteins are shown in pink C)
Scatter plot of the values of ratios of intrinsic degradation
constants kB,d/kA,d vs. the ratios of synthesis rates VB/VA. The
median values of kB,d/kA,d and VB/VA for the population are
indicated with dashed lines. Coloring of points indicates
ribosomal, proteasome and heat shock proteins.
(TIF)
Figure S12 Comparing the fitting and the resulting
kd,app and VB/VA ratios from two pcSILAC experiments.
Values of kinetic parameters for 462 proteins fully quantified in
both pcSILAC experiments are shown, together with the value of
the residual norm of the error (sum parameter ResNorm for both
experiments). ResNorm gives a measure of the quality of the fit
between experimental data and the model. Proteins with lower
summed ResNorm, indicating a good fit, are usually closer to the
diagonal than the ones with higher values of ResNorm.
(TIF)
Figure S13 Comparing the fitting and the resulting
steady state values of protein concentrations in control
and treated samples from two pcSILAC experiments. A)
Values of predicted steady-state concentrations for 462 proteins
fully quantified in both pcSILAC experiments are shown, color-
coded by the value of the residual norm of the error (resNorm
parameter, sum for both experiments). ResNorm gives a measure
of the quality of the fit between experimental data and the model.
Proteins with lower summed resNorm, indicating a good fit, are
usually closer to the diagonal than the ones with higher values of
resNorm. B) is an enlargment of the plot in A).
(TIF)
Figure S14 Comparison of half-lives obtained by pcSI-
LAC with published datasets. Half-lives were retrieved from
the supplementary data of three published works and are
compared with data from pcSILAC experiment 2 (untreated
cells). Protein groups were matched by gene name. The data were
acquired on the following cell lines; Wu et al: CAL27, oral
adenosquamous carcinoma; Schwanha¨usser et al: mouse NIH 3T3
fibroblasts; Boisvert et al: HeLa cells (whole cell half-life dataset).
A) Boxplot of the four datasets (outliers not shown) Note: the
dataset of Boisvert et al contained a large number of stable
proteins for which half-lives could not be calculated accurately and
were given a value of 999. These were not used for this plot B)
Kernel density estimate for three out of the four datasets C)
Scatterplot and Pearson’s correlation coefficient of values from
pcSILAC against those reported by Wu et al. 1. Boisvert, F.-M.,
Ahmad, Y., Gierlinski, M., Charrie`re, F., Lamont, D., Scott, M.,
Barton, G., et al. (2012). Molecular & cellular proteomics: MCP,
11(3). 2. Wu, Z., Moghaddas Gholami, A., & Kuster, B. (2012).
Molecular & cellular proteomics: MCP, 11(6). 3. Schwanha¨usser,
B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen,
W., et al. (2011). Nature, 473(7347), 337–42.
(TIF)
Figure S15 Correlation between synthesis rates, decay
rate constants and changes in net protein levels in the
two pcSILAC experiments. Pearson’s r values are shown. Plots
represent the datasets highlighted in yellow in the tables. A)
Correlation of kA, kB and log2(VB/VA) with the experimentally
determined stSILAC ratio at 20h in experiment 1. B) Correlation
of kA, kB and log2(VB/VA) with computationally derived ratio of
net protein levels in experiment 2 (20h).
(TIF)
Figure S16 Example of proteins with poor fitting to the
model. Ratios (H/M)K, measuring newly synthesized protein
levels from experiment 2 are shown. Values are after correction for
mixing inequality and log2 transformation. Some proteins with
apparent multiphasic behavior are shown in red, together with their
value of the ResNorm parameter (Blue), which is a measure of the
quality of the fitting. Most proteins highlighted here have values of
ResNorm well above the median (0.18) of ResNorm for the whole
population. It is to be noted however that, since the fitting is performed
on 6 series of ratios, deviations due to noise in one series can be
compensated by other values. DNAJB1 and GRP78 were quantitated
with large numbers of peptides and thus their values should be reliable
and reflect a complex temporal dynamic of changes.
(TIF)
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Table S1 Global statistics incl. numbers of quantified
peptides for pcSILAC experiments 1 and 2, each with
replicates 1 and 2 (.XLS).
(XLS)
Table S2 data for pcSILAC experiment 1 after Max-
Quant processing (before model application and rates
calculations). Includes all ratios H/M,H/L,M/L for both K-
and R-peptides at all time points and replicates (.XLS).
(XLSX)
Table S3 Data for pcSILAC experiment 2 after Max-
Quant processing (before model application and rates
calculations). Includes all ratios H/M,H/L,M/L for both K-
and R-peptides at all time points and replicates (.XLS).
(XLSX)
Table S4 Kinetic parameters calculated for each repli-
cate of experiment 1 and experiment 2, including
statistics (.XLS).
(XLSX)
Table S5 Gene Ontology annotation enrichment analy-
sis performed on decay rates kd and synthesis rates V
for GA-treated and DMSO cells (.XLS).
(XLSX)
Supplementary Information S1. Main supporting in-
formation including i) detailed discussion of isotope
patterns of various types of peptides ii) Description of
the mathematical model and computational frame-
work for pcSILAC including derivation of all kinetic
parameters and fluxes iii) all supplementary figures
S1-S16 in one file to facilitate viewing after download
(PDF).
(PDF)
File S1 Scripts (perl) for processing of MaxQuant output (first
part of the pcSILAC data analysis pipeline) (txt document).
(TXT)
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